Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Moderna Inc MRNA

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular... see more

NDAQ:MRNA - Post Discussion

Moderna Inc > Anyone know if Moderna has diagnostic tool
View:
Post by frankman on Feb 01, 2022 8:41am

Anyone know if Moderna has diagnostic tool

diagnostic for evaluating T-cell immune response to SARS-CoV-2?
Comment by Hempminister on Feb 15, 2022 10:24am
/>https://www.facebook.com/100027310376899/posts/793948874858784/?fs=e&s=cl
Comment by Hempminister on Feb 15, 2022 10:26am
Therma Brights (TSXV:THRM) AcuVid COVID-19 Rapid Antigen Saliva Test exceeds U.S. FDAs EUA requirements Health Care, Market News TSXV:THRM $79.03M
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities